VIT-ALK, a Novel Alectinib-Sensitive Fusion Gene in Lung Adenocarcinoma

被引：4
|
作者：
Hu, Song [1 ]
Li, Qing [2 ]
Peng, Wanda [1 ]
Feng, Chunlai [1 ]
Zhang, Sujuan [1 ]
Li, Chong [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 3, Dept Resp Med, Changzhou 213000, Jiangsu, Taiwan
[2] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou, Jiangsu, Taiwan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 05期
关键词：
D O I：
10.1016/j.jtho.2017.11.134
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E72 / E74
页数：4
相关论文
共 50 条
  • [1] A novel alectinib-sensitive CTNND1-ALK fusion in a lung adenocarcinoma patient: a case report
    Xiang Tian
    Qiong Liao
    Qidong Yang
    Lin Chen
    Mingzhe Xiao
    Yuanjian Cheng
    [J]. Investigational New Drugs, 2022, 40 : 850 - 853
  • [2] A novel alectinib-sensitive CTNND1-ALK fusion in a lung adenocarcinoma patient: a case report
    Tian, Xiang
    Liao, Qiong
    Yang, Qidong
    Chen, Lin
    Xiao, Mingzhe
    Cheng, Yuanjian
    [J]. INVESTIGATIONAL NEW DRUGS, 2022, 40 (04) : 850 - 853
  • [3] Identification of a novel ALK inhibitor-sensitive PRKCE-ALK gene fusion in lung adenocarcinoma
    Wang, Lan
    Li, Lei
    Zhou, Xue
    Zhang, Dongdong
    [J]. LUNG CANCER, 2024, 191
  • [4] SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma
    Liang, Yuepei
    Wang, Yang
    Wang, Wenjing
    Zhao, Juan
    Xu, Mian
    Zheng, Min
    [J]. CLINICAL GENETICS, 2021, 99 (03) : 488 - 489
  • [5] Dramatic response to alectinib in a lung adenocarcinoma patient harboring a Novel SSFA2-ALK fusion
    Xinyi Lin
    Xiaojuan Yang
    Yuan Tan
    Qianqian Duan
    Mei He
    [J]. Investigational New Drugs, 2022, 40 : 1160 - 1163
  • [6] Response of a Novel KANK1::ALK Fusion to Alectinib in an Advanced Lung Adenocarcinoma: A Case Report
    Tang, Quanying
    Li, Tong
    Ren, Fan
    Li, Xuanguang
    Cao, WeiBo
    Yu, Haochuan
    Mao, Fuling
    Cao, Cancan
    Zu, Lingling
    Xu, Song
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (02):
  • [7] Dramatic response to alectinib in a lung adenocarcinoma patient harboring a Novel SSFA2-ALK fusion
    Lin, Xinyi
    Yang, Xiaojuan
    Tan, Yuan
    Duan, Qianqian
    He, Mei
    [J]. INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) : 1160 - 1163
  • [8] Targeting SLMAP-ALK-a novel gene fusion in lung adenocarcinoma
    Pagan, Carlos
    Barua, Subit
    Hsiao, Susan J.
    Mansukhani, Mahesh
    Saqi, Anjali
    Murty, Vundavalli
    Fernandes, Helen
    [J]. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2019, 5 (03):
  • [9] A Novel Fusion of TPR and ALK in Lung Adenocarcinoma
    Choi, Yoon-La
    Lira, Maruja E.
    Hong, Mineui
    Kim, Ryong Nam
    Choi, So-Jung
    Song, Ji-Young
    Pandy, Kinnari
    Mann, Derrick L.
    Stahl, Joshua A.
    Peckham, Heather E.
    Zheng, Zongli
    Han, Joungho
    Mao, Mao
    Kim, Jhingook
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : 563 - 566
  • [10] TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma
    Mao, Weijun
    Chen, Ruo
    Zhang, Junling
    Zheng, Mingfeng
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E37 - E39
12345